Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future-Reference-Cited by-同舟云学术

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

Published:2017-08-17 Issue:1 Volume:48 Page:52-108
ISSN:1040-8444
Container-title:Critical Reviews in Toxicology
language:en
Short-container-title:Critical Reviews in Toxicology

Author:

Davidson Melissa A.¹²,Mattison Donald R.²³,Azoulay Laurent⁴⁵,Krewski Daniel¹²³⁶

Affiliation:

1. Faculty of Health Sciences, University of Ottawa, Ottawa, Canada;

2. McLaughlin Centre for Population Health Risk Assessment, Ottawa, Canada;

3. Risk Sciences International, Ottawa, Canada;

4. Center for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, Montreal, Canada;

5. Department of Oncology, McGill University, Montreal, Canada;

6. Faculty of Medicine, University of Ottawa, Ottawa, Canada

Funder

Natural Sciences and Engineering Council of Canada

Government of Ontario

Natural Sciences and Engineering Research Council of Canada

Publisher

Informa UK Limited

Subject

Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408444.2017.1351420

Reference698 articles.

1. PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations

2. Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis

3. Standards of Medical Care in Diabetes—2014

4. Bone health in diabetes: considerations for clinical management

5. [AFSSAPS] Agence française de sécurité sanitaire des produits de santé. Use of medications containing pioglitazone (Actos®, Competact®) Suspended. 2011. [accessed 24 Feb 2012]. www.afssaps.fr/content/download/34175/447382/version/1/file/Press-release-Suspension-Pioglitazone.pdf.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements;ChemistryOpen;2024-09-09

2. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management;Diabetologia;2024-08-19

3. Medical treatments for abdominal aortic aneurysm: an overview of clinical trials;Expert Opinion on Investigational Drugs;2024-07-11

4. Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review;Cell Biochemistry and Biophysics;2024-07-02

5. Pioglitazone‐induced alterations of purine metabolism in healthy male subjects;Clinical and Translational Science;2024-05